About the role
University College London (UCL) is one of the world’s leading universities, known for its academic excellence, global outlook, and commitment to innovation. UCL Division of Surgery and Interventional Science conducts pioneering research in healthcare delivery and technologies, with research spanning the full translational pathway, reflected in the multidisciplinary nature of our team.
Applicants should hold a Master’s degree in a subject related to life sciences, biomedical science, physics, chemistry, or chemical engineering, with knowledge or experience in nanomedicine, radiotherapy and cell culture. The position offers supervision by Dr Kate Ricketts and Prof Gary Royle, and secondments to leading European institutions (3–6 months).
Please note this is a fixed-term role for a period of 36 months, starting on 1st July or an agreed date, but no later than the 1st September .